Skip to main content
. Author manuscript; available in PMC: 2016 Aug 4.
Published in final edited form as: Am J Prev Med. 2014 Sep 11;47(5):624–628. doi: 10.1016/j.amepre.2014.06.017

Table 2.

Grantee-specific coverage, by intervention, WIC eligibility, and status, 2011 NIS and 2010 WIC-LARS, % (SE)

Coveragea at 24 months in grantees categorized as A&R Onlyb Coveragea at 24 months in grantees categorized as A&R Plusb


Awardee (n) WIC
ineligiblec
WIC eligible, current
participantc
Awardee (n) WIC
ineligiblec
WIC eligible, current
participantc
Arizona (141) 64 (7.5) 63 (10.0) Alabama (214) 69 (6.2) 66 (5.7)

Arkansas (158) 83 (4.4) 73 (6.5) Alaska (137) 74 (6.2) 65 (7.5)

California (235) 77 (5.0) 72 (5.0) Chicago (231) 76 (4.2) 76 (7.2)

Colorado (216) 72 (7.1) 87 (5.9) Connecticut (232) 75 (3.6) 64 (8.6)

Delaware (174) 73 (5.7) 66 (7.5) Dist of Columbia (213) 77 (3.9) 72 (7.5)

Georgia (186) 88 (3.2) 64 (7.1) Florida (182) 79 (4.5) 67 (7.4)

Houston (173) 60 (6.2) 73 (5.8) Hawaii (157) 65 (8.3) 86 (4.6)

Indiana (210) 79 (4.6) 67 (6.7) Idaho (144) 61 (7.0) 73 (8.8)

Iowa (181) 80 (4.1) 59 (11.7) Illinois (189) 70 (5.4) 58 (9.1)

Maine (155) 72 (5.0) 79 (5.7) Kentucky (144) 89 (3.2) 85 (6.3)

Michigan (210) 75 (5.0) 73 (7.2) Louisiana (138) 70 (6.5) 83 (5.6)

Minnesota (148) 82 (3.9) 59 (10.3) Maryland (356) 77 (3.8) 68 (7.8)

Missouri (207) 68 (5.1) 54 (7.3) Massachusetts (182) 83 (3.3) 88 (9.8)

Nebraska (166) 85 (3.5) 66 (9.3) Mississippi (155) 77 (6.4) 81 (5.2)

Nevada (157) 68 (6.4) 64 (9.4) New Hampshire (135) 72 (5.4) 65 (11.0)

New Jersey (178) 67 (4.5) 70 (8.2) New York (145) 68 (4.8) 74 (9.9)

New Mexico (148) 79 (4.7) 76 (6.2) North Carolina (138) 72 (6.2) 72 (8.4)

New York City (160) 61 (5.8) 67 (6.4) North Dakota (139) 78 (6.3) 64 (11.3)

Ohio (164) 85 (4.4) 81 (5.9) Pennsylvania (372) 73 (4.0) 73 (5.9)

Oklahoma (138) 57 (9.6) 63 (7.3) South Dakota (141) 83 (4.9) 66 (10.9)

Oregon (155) 71 (5.8) 71 (10.6) Tennessee (134) 76 (6.3) 64 (8.2)

Rhode Island (222) 71 (4.1) 76 (6.8) Texas (716) 71 (5.1) 71 (4.3)

South Carolina (116) 71 (7.3) 74 (7.3) Utah (188) 73 (5.1) 56 (10.8)

Vermont (148) 75 (5.9) 73 (6.7) Wyoming (147) 66 (6.7) 58 (11.2)

West Virginia (186) 74 (5.0) 65 (5.6)

Wisconsin (187) 77 (4.4) 79 (6.9)

Note: Boldface indicates significant difference in coverage compared to WIC-ineligible children (p<0.05). Logistic regression estimates weighted to account for sampling.

a

Coverage defined as up to date on 4:3:1:*:3:1:4 series= ≥4 doses of DTaP, ≥3 doses of poliovirus, ≥1 dose of measles, ≥3 doses of Hib, ≥3 doses of HepB, ≥1 dose of varicella, and ≥4 doses of PCV, excluding Hib.

b

Based on intervention primarily implemented among majority of grantee WIC sites.

c

WIC income eligibility and participation status determined at time of interview; income eligibility based on family income ≤185% of federal poverty level.

A&R, assessment and referral; DTaP, diphtheria, tetanus toxoids, and acelluar pertussis–containing vaccine; HepB, hepatitis B; Hib, Haemophilus influenza type b; NIS, National Immunization Surveys; PCV, pneumococcal conjugate vaccine; WIC, Special Supplemental Nutrition Program for Women, Infants, and Children; WIC-LARS, WIC Linkage Annual Report Survey.